The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

Mise à jour : Il y a 4 ans
Référence : NCT00076076

Femme et Homme

Extrait

The purpose of this study is to confirm the dose of roflumilast to be used for asthma management by comparing the effects of 250 mcg and 500 mcg oral roflumilast with placebo on pulmonary function and asthma symptoms.


Critère d'inclusion

  • Asthma

Liens